JP2010530001A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530001A5
JP2010530001A5 JP2010512395A JP2010512395A JP2010530001A5 JP 2010530001 A5 JP2010530001 A5 JP 2010530001A5 JP 2010512395 A JP2010512395 A JP 2010512395A JP 2010512395 A JP2010512395 A JP 2010512395A JP 2010530001 A5 JP2010530001 A5 JP 2010530001A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
sulfide
blood flow
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010512395A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010530001A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/066973 external-priority patent/WO2008157393A1/en
Publication of JP2010530001A publication Critical patent/JP2010530001A/ja
Publication of JP2010530001A5 publication Critical patent/JP2010530001A5/ja
Pending legal-status Critical Current

Links

JP2010512395A 2007-06-15 2008-06-13 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用 Pending JP2010530001A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94444407P 2007-06-15 2007-06-15
PCT/US2008/066973 WO2008157393A1 (en) 2007-06-15 2008-06-13 Compositions comprising sulfide alone or in combination with nitric oxide and their use to

Publications (2)

Publication Number Publication Date
JP2010530001A JP2010530001A (ja) 2010-09-02
JP2010530001A5 true JP2010530001A5 (enExample) 2011-07-28

Family

ID=39670390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010512395A Pending JP2010530001A (ja) 2007-06-15 2008-06-13 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用

Country Status (4)

Country Link
US (3) US20100247680A1 (enExample)
EP (1) EP2155213A1 (enExample)
JP (1) JP2010530001A (enExample)
WO (1) WO2008157393A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1879599E (pt) * 2005-04-20 2014-01-23 Hutchinson Fred Cancer Res Métodos, composições e artigos de fabrico para aumentar a capacidade de sobrevivência de células, tecidos, órgãos, e organismos
EP2669269B1 (en) 2005-05-27 2019-05-22 The University of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US7923037B2 (en) 2006-10-05 2011-04-12 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
US20100183748A1 (en) * 2009-01-21 2010-07-22 Ikaria, Inc. Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury
US8541396B2 (en) 2009-04-24 2013-09-24 National University Of Singapore Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
SI3498328T1 (sl) 2009-05-27 2021-03-31 Mallinckrodt Hospital Products IP Limited Pripomoček za spajanje indeksiranega ventila in sestava posode pod tlakom s pritrdilnim obročem in za linearno sprožitev sestava sprožilnika pri odvajanju tekočin s pripomočkom za reguliranje dovajanja zdravila
EP2467173B8 (en) 2009-08-21 2019-06-19 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
WO2015120458A1 (en) 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
AU2018322317B2 (en) 2017-08-25 2023-11-23 Mallinckrodt Pharmaceuticals Ireland Limited Methods to improve organ viability
TWI650326B (zh) 2017-10-24 2019-02-11 國立交通大學 醫藥組合物、化合物的用途及合成方法
JP6618976B2 (ja) * 2017-11-14 2019-12-11 イノ セラピューティクス エルエルシー 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法
US20220241322A1 (en) * 2019-06-28 2022-08-04 Sumitomo Seika Chemicals Co., Ltd. Wound-treating gas composition, and wound-treating apparatus
CN111228223B (zh) * 2020-03-06 2021-06-18 同济大学 一种促进伤口愈合的聚合物囊泡及其制备方法和应用
CN114099419B (zh) * 2021-11-19 2023-03-24 苏州大学 一种载硫氢化钠可注射纳米纤维化水凝胶及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160792T3 (es) * 1995-04-20 2001-11-16 Clariant Finance Bvi Ltd Suspensiones liquidas estables de colorantes al azufre y metodo para analizar las mismas.
US20020132845A1 (en) * 2000-12-15 2002-09-19 Miller Guy Michael Compositions and methods for the prevention and treatment of tissue ischemia
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
CN1674942A (zh) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
US20050136125A1 (en) * 2003-10-22 2005-06-23 Roth Mark B. Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
US20080226750A1 (en) * 2006-04-20 2008-09-18 Fred Hutchinson Cancer Research Center Methods, Compositions and Articles of Manufacture for Treating Shock and Other Adverse Conditions
KR101538727B1 (ko) * 2006-10-05 2015-07-22 이카리아 인코포레이티드 액체 칼코게나이드 조성물 및 이의 제조방법과 사용방법
WO2008079993A2 (en) * 2006-12-22 2008-07-03 Ikaria, Inc. Combinations of nitric oxide and sulfide and methods of use and manufacture thereof

Similar Documents

Publication Publication Date Title
JP2011520917A5 (enExample)
JP2024540183A5 (enExample)
JP2014515028A5 (enExample)
JP2021504423A5 (enExample)
JP2007514750A5 (enExample)
WO2011005538A3 (en) Methods and devices for remote ischemic preconditioning and near-continuous blood pressure monitoring
JP2007277274A5 (enExample)
JP2011057709A5 (enExample)
IL155524A (en) Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
JP2011503212A5 (enExample)
JP2010538020A5 (enExample)
JP2008545703A5 (enExample)
El-Tahan Preoperative ephedrine counters hypotension with propofol anesthesia during valve surgery: a dose dependent study
De Caridi et al. Effectiveness of prostaglandin E1 in patients with mixed arterial and venous ulcers of the lower limbs
EA201070084A1 (ru) Новое применение известных фармакологически активных химических соединений
EA201071138A1 (ru) Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
RU2004136583A (ru) Применение валсартана или его метаболита для ингибирования агрегации тромбоцитов
CN103340863A (zh) 烟酰胺在制备治疗糖尿病伤口愈合药物中的应用
Awsakulsutthi et al. Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital
HRP20200897T1 (hr) Parenteralna formulacija esmolola
RU2004121780A (ru) Способ лечения
Ahmed et al. Anesthetic management of a patient with hypertrophic obstructive cardiomyopathy undergoing modified radical mastectomy
JP2007523111A5 (enExample)
Shaff et al. Anesthetic management for transurethral resection of the bladder in a 74-year-old man with uncorrected tetralogy of Fallot
Kang et al. Effect of prophylactic continuous infusion of isosorbide dinitrate on myocardial protection and hemodynamics in patients undergoing off-pump coronary bypass surgery